Brozovich B, Cattell W R, Cottrall M F, Gwyther M M, McMillan J M, Malpas J S, Salsbury A, Trott N G
Br Med J. 1971 Mar 27;1(5751):695-8. doi: 10.1136/bmj.1.5751.695.
Thirteen patients with chronic renal failure maintained on regular renal dialysis were studied. Seven proved to have iron deficiency on the basis of marrow iron studies, reticulocyte iron uptake, and saturation of the serum iron-binding capacity. They absorbed iron when given it by mouth and were able to utilize it for haemoglobin formation. Iron-deficient patients given 600 mg of ferrous sulphate daily for three months showed an increase in haemoglobin, but the failure to replace stores of iron is probably related to their relatively limited ability to absorb iron and the variable but sometimes considerable blood loss occurring with each dialysis.The loss may be occult, and prolonged iron therapy may be required. This is most safely achieved by giving iron by mouth.
对13例接受定期肾脏透析治疗的慢性肾衰竭患者进行了研究。根据骨髓铁研究、网织红细胞铁摄取及血清铁结合能力饱和度,7例被证实存在缺铁。他们口服铁剂后能够吸收,并能将其用于血红蛋白的合成。缺铁患者每日服用600毫克硫酸亚铁,持续三个月,血红蛋白有所增加,但未能补充铁储备可能与他们相对有限的铁吸收能力以及每次透析时发生的可变但有时相当大量的失血有关。失血可能是隐匿性的,可能需要长期铁剂治疗。通过口服铁剂最安全地实现这一点。